Nuveen’s HCA Healthcare HCA Stock Holding History

Nuveen’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,200	Closed	-$4K	–	3223
2022 Q3	$4K	Buy	+22,200	New	+$4.42M	﹤0.01%	3219

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nuveen's HCA Position: Q2 2026 in Review

Nuveen reduced its HCA Healthcare (HCA) stake by 35% in Q2 2026, selling an estimated $115M and leaving 511,927 shares worth $200M. The position accounts for 0.05% of the portfolio, ranked #278.

Nuveen first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. The position peaked at $725M in Q3 2024. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Nuveen held 511,927 shares of HCA Healthcare worth $200M as of Q2 2026.
Nuveen sold 271,621 HCA Healthcare shares in Q2 2026, an estimated $115M.
HCA Healthcare made up 0.05% of Nuveen's portfolio in Q2 2026, its #278 holding.
Nuveen first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
Nuveen's HCA Healthcare position peaked at $725M in Q3 2024.
1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.